期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Steroids in acute respiratory distress syndrome:A panacea or still a puzzle?
1
作者 Sharmili Sinha Rohit Patnaik Srikant Behera 《World Journal of Critical Care Medicine》 2024年第2期93-105,共13页
Acute respiratory distress syndrome(ARDS)is a unique entity marked by various etiologies and heterogenous pathophysiologies.There remain concerns regarding the efficacy of particular medications for each severity leve... Acute respiratory distress syndrome(ARDS)is a unique entity marked by various etiologies and heterogenous pathophysiologies.There remain concerns regarding the efficacy of particular medications for each severity level apart from respiratory support.Among several pharmacotherapies which have been examined in the treatment of ARDS,corticosteroids,in particular,have demonstrated potential for improving the resolution of ARDS.Nevertheless,it is imperative to consider the potential adverse effects of hyperglycemia,susceptibility to hospital-acquired infections,and the development of intensive care unit acquired weakness when administering corticosteroids.Thus far,a multitude of trials spanning several decades have investigated the role of corticosteroids in ARDS.Further stringent trials are necessary to identify particular subgroups before implementing corticosteroids more widely in the treatment of ARDS.This review article provides a concise overview of the most recent evidence regarding the role and impact of corticosteroids in the management of ARDS. 展开更多
关键词 Acute respiratory distress syndrome CORTICOSTEROIDS Septic shock community acquired pneumonia COVID-19 Randomized controlled trials
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部